We note that in Jun 2012, Impax entered into a development, supply and distribution deal with TOLMAR, Inc. Under the agreement, TOLMAR gave Impax an exclusive license to commercialize generic Solaraze ...

Alembic’s subsidiary, Aleor Dermaceuticals, has received the Food and Drug Administration’s approval for diclofenac sodium topical gel 3%, a generic of Fougera’s Solaraze topical gel. The medication ...

PRINCETON, N.J. — Sandoz has launched an authorized generic version of a topical drug for treating actinic keratosis, the company said. Sandoz, the generics arm of Swiss drug maker Novartis, announced ...

Solaraze Gel(diclofenac sodium 3%, from PharmaDerm) is now available as a 100g tube to provide afull course of therapy for most patients. The 50g tubes will be discontinuedafter January 30, 2009.

DRUGS group Shire Pharmaceuticals has signed a £15m deal to market a treatment that tackles a skin condition caused by over exposure to the sun. The group has been awarded the European distribution ...

Troubled pharmaceutical company Bioglan Pharma said today it had reached a deal with Skyepharma, US firm Quintiles and its banks… Troubled pharmaceutical company Bioglan Pharma said today it had ...

Impax Labs and Tolmar, Inc. announced that the FDA has granted final approval of Tolmar’s abbreviated New Drug Application (ANDA) for Diclofenac Sodium 3% Gel, the generic version of PharmaDerm’s ...

The company's current portfolio consists of 110 products authorized for distribution in the US marketplace and 61 ANDA‘s pending approval with the USFDA. Advisory Alert: It has come to our attention ...

New Delhi, Sep 14: Glenmark Pharmaceuticals has received final approval from the US health regulator for generic Diclofenac Sodium gel used for treatment of skin lesion. "Glenmark Pharmaceuticals Inc ...